Doctor Says J&J/Cordis Stents Infringe Patent

Law360, New York (October 10, 2007, 12:00 AM EDT) -- A doctor from New Jersey is suing Johnson & Johnson and subsidiary Cordis Corp. in a bid to tap into the multibillion-dollar market for drug-eluting coronary stents, claiming that the defendants' stents infringe a patent he secured in 1997.

Bruce N. Saffran, M.D., Ph.D., filed the lawsuit on Tuesday, asking an east Texas court to award treble damages and issue a permanent injunction barring the alleged infringement of the patent-in-suit.

J&J/Cordis and Boston Scientific Corp. are currently the only two companies with regulatory approval to market...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.